COMPARING JAK INHIBITORS AND STANDARD THERAPIES IN REFRACTORY MYOPATHIES: IMPACT ON CARDIOVASCULAR, MALIGNANCY, AND DISEASE ACTIVITY OUTCOMES

Authors

Publication/Presentation Date

6-2025

Volume

84

Issue

1

First Page

1144

Last Page

1144

Disciplines

Medicine and Health Sciences

Department(s)

Fellows and Residents

Document Type

Article

Share

COinS